THC Stock Chart & Stats
$4620.00
$685.50(19.26%)
At close: 4:00 PM EDT
$4620.00
$685.50(19.26%)
Day’s Range― - ―
52-Week Range$3,268.16 - $4,942.25
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$411.37B
Enterprise Value$35.32B
Total Cash (Recent Filing)$2.67B
Total Debt (Recent Filing)$164.00M
Price to Earnings (P/E)7.8
Beta-0.03
Next Earnings
Feb 11, 2027EPS Estimate
102.28Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)34.71
Shares Outstanding80,519,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)4.25
Price to Sales (P/S)0.84
P/FCF Ratio7.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$5,553.08Price Target Upside20.20% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
EPS Forecast (FY)400.27
Revenue Forecast (FY)$419.72B
Bulls Say, Bears Say
Bulls Say
Ambulatory Growth And MarginsUSPI combines strong profitability with a scalable outpatient model, supporting durable earnings expansion as procedures migrate to ambulatory settings. Its high margins, physician alignment, and continued development and acquisition activity can strengthen Tenet’s competitive position over the next several quarters.
Strong Cash GenerationRobust free cash flow and substantial cash on hand improve Tenet’s ability to fund growth, reduce financial stress, and return capital to shareholders. The absence of revolver borrowings also provides liquidity flexibility if operating conditions or reimbursement trends become less favorable.
Commercial Pricing VisibilityFavorable commercial pricing and high contract coverage provide greater visibility into reimbursement revenue than reliance on spot negotiations would allow. This supports margin planning, helps offset cost inflation, and gives management a more stable foundation for near-term operating execution.
Bears Say
Medicaid And Exchange ExposureTenet’s substantial exposure to Medicaid expansion states leaves reimbursement and patient coverage vulnerable to policy changes. Potential work requirements, exchange volume pressure, and uncertainty around supplemental payments could reduce admissions, increase uncompensated care, and pressure revenue growth.
Nonrecurring Conifer BenefitRecent earnings benefited materially from Conifer transition activities that management identifies as nonrecurring. As that contribution rolls off, reported EBITDA growth will face a tougher comparison, requiring hospital and USPI operations to deliver sufficient underlying improvement to sustain momentum.
Balance-sheet Trend InconsistencyThe dramatic improvement in reported leverage is encouraging but not a steady multi-year trend, making the durability of Tenet’s balance-sheet strength harder to underwrite. Historical leverage was high, so changes in debt or equity could materially affect flexibility and financial risk.
Tenet Healthcare News
THC FAQ
What was Tenet Healthcare’s price range in the past 12 months?
Tenet Healthcare lowest stock price was $3268.16 and its highest was $4942.25 in the past 12 months.
What is Tenet Healthcare’s market cap?
Tenet Healthcare’s market cap is $411.37B.
When is Tenet Healthcare’s upcoming earnings report date?
Tenet Healthcare’s upcoming earnings report date is Feb 11, 2027 which is in 104 days.
How were Tenet Healthcare’s earnings last quarter?
Tenet Healthcare released its earnings results on Oct 29, 2026. The company reported $125.378 earnings per share for the quarter, beating the consensus estimate of $88.293 by $37.085.
Is Tenet Healthcare overvalued?
According to Wall Street analysts Tenet Healthcare’s price is currently Undervalued.
Does Tenet Healthcare pay dividends?
Tenet Healthcare does not currently pay dividends.
What is Tenet Healthcare’s EPS estimate?
Tenet Healthcare’s EPS estimate is 102.28.
How many shares outstanding does Tenet Healthcare have?
Tenet Healthcare has 80,519,000 shares outstanding.
What happened to Tenet Healthcare’s price movement after its last earnings report?
Tenet Healthcare reported an EPS of $125.378 in its last earnings report, beating expectations of $88.293. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Tenet Healthcare?
Currently, no hedge funds are holding shares in MX:THC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Tenet Healthcare Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5,553.08 (20.20% Upside)
$5,553.08 (20.20% Upside)
Blogger Sentiment
Bullish
MX:THC Sentiment 93%
Sector Average 65%
Sector Average 65%
Insider Transactions
Sold Shares
Worth $843.2M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
29.37%
12-Months-Change
Fundamentals
Return on Equity
65.18%
Trailing 12-Months
Asset Growth
6.89%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Tenet Healthcare
Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. Within its network of acute care facilities, Tenet delivers a full spectrum of essential services. These include core hospital functions such as operating and recovery suites, radiology and respiratory therapy, clinical laboratories, and on-site pharmacies. The organization also provides high-acuity patient care through intensive, critical, and coronary care units. Specialized medical services cover areas like cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics, alongside various outpatient treatments, including physical therapy. Advanced surgical capabilities feature cardiothoracic, complex spinal, and neurosurgery, as well as neonatal intensive care. Tenet extends its offerings to ultra-specialized quaternary care, exemplified by heart and kidney transplant programs, and sophisticated procedures such as limb-salvaging vascular interventions, acute Level 1 trauma care, intravascular stroke treatment, minimally invasive cardiac valve replacements, advanced imaging, and telemedicine access. Beyond its hospital network, Tenet manages numerous other clinical sites. These encompass outpatient surgical centers, immediate care facilities, diagnostic imaging centers, dedicated surgical hospitals, off-campus emergency departments, and micro-hospitals. Through its Conifer segment, the company furnishes critical healthcare business process solutions. These administrative services, offered to hospitals, health systems, physician practices, employers, and other clients, include financial administration for patient accounts (revenue cycle management), support for patient communications and engagement, and outcome-focused care strategies. As of February 9, 2022, Tenet's operational footprint included 60 hospitals and roughly 550 additional medical facilities. This count of additional sites comprises surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and various other clinical locations. Tenet Healthcare Corporation was established in 1975 and maintains its principal office in Dallas, Texas.
THC Company Deck
THC Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was strongly positive overall. Tenet delivered substantial earnings, margin, cash flow, and share-repurchase performance; raised its 2026 revenue, EBITDA, and free cash flow guidance; and expressed confidence in core EBITDA growth for 2027. The principal challenges were exchange-related volume and coverage pressure, lower USPI case volumes, the nonrecurring nature of Conifer transition contributions, and uncertainty surrounding Medicaid work requirements, HR 1, and future regulatory conditions.View all MX:THC earnings summariesTHC Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$5,553.08
▲(20.20% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Community Health
―
HCA Healthcare
―
Universal Health
―
Surgery Partners
―
Ardent Health Partners, Inc.
―










